DSIP

DSIP Nasal Spray is supplied by Crystal Peptides as a catalogued research material in this exact format and strength: nasal spray, 10mg/10ml. This catalogue designation identifies the presentation; it does not establish batch composition, analytical content or suitability for any biological application.

DSIP denotes Delta Sleep-Inducing Peptide, a linear nonapeptide associated with historical sleep and physiological research. Its literature identity maps to the free peptide sequence H-WAGGDASGE-OH. That mapping alone does not establish the salt, counter-ion, peptide content or purity of this formulated material; these attributes require documentation linked to the exact batch.

Chemical properties and registry information

Registry identifiers describe the referenced molecular entity, not the complete spray formulation. Their applicability depends on the confirmed sequence, termini and material form. Batch records take precedence when defining the supplied material.

Research background and published evidence

Published research

DSIP has been examined in historical physiological and sleep-research models, including small controlled human studies. The supplied literature context describes limited or inconsistent observations rather than a reproducible product-performance finding. These publications concern the materials and experimental conditions reported by their authors, not this catalogue presentation or its individual batches.

Current scientific understanding

The research record remains limited and does not establish a reliable therapeutic effect. The compound name should not be interpreted as evidence that this formulation produces a particular sleep-related response. Historical observations provide context for scientific investigation, but do not validate this nasal spray as equivalent to the materials studied.

Interpretation requires attention to molecular identity, formulation, analytical characterization and experimental design. No medicinal authorization or clinical suitability is inferred from the DSIP name, registry listing or research-use designation.

Formulation note

Published DSIP research mostly used other materials or routes. Findings from injected or differently formulated material cannot be transferred to this nasal spray formulation. Differences in excipients, material composition and experimental context prevent direct assumptions of equivalence. The stated nasal spray, 10mg/10ml presentation is a catalogue specification, not evidence of formulation-specific biological performance or stability.

Quality and testing

Quality information must come from a batch-specific certificate of analysis (CoA) matching this product, presentation and lot. A report for another DSIP format, strength or batch is not evidence for this material. Confirm which identity, purity and content measurements are actually documented, together with the methods and reporting basis.

Chromatographic area purity, peptide identity, quantitative content, counter-ion composition, microbiological quality and elemental impurities are distinct analytical attributes. One result does not establish the others. Treat only tests supported by the matching report as available, and verify formulation details against the corresponding CoA and safety data sheet (SDS).

For laboratory research use only by qualified professionals. Not for human or veterinary use. No dosing directions are provided. Purchasers are responsible for compliance with applicable institutional and jurisdiction-specific requirements.